Kim SJ - Search Results

1

Effect of IN-1130, a small molecule inhibitor of transforming growth factor-beta type I receptor/activin receptor-like kinase-5, on prostate cancer cells.

Lee GT, Hong JH, Mueller TJ, Watson JA, Kwak C, Sheen YY, Kim DK, Kim SJ, Kim IY. Lee GT, et al. Among authors: kim iy, kim dk, kim sj. J Urol. 2008 Dec;180(6):2660-7. doi: 10.1016/j.juro.2008.08.008. Epub 2008 Oct 31. J Urol. 2008. PMID: 18951571

2

Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells.

Kim HT, Kim BC, Kim IY, Mamura M, Seong DH, Jang JJ, Kim SJ. Kim HT, et al. Among authors: kim iy, kim bc, kim sj. J Biol Chem. 2002 Sep 6;277(36):32510-5. doi: 10.1074/jbc.M202852200. Epub 2002 Jun 25. J Biol Chem. 2002. PMID: 12084714 Free article.

3

Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway.

Kim IY, Seong DH, Kim BC, Lee DK, Remaley AT, Leach F, Morton RA, Kim SJ. Kim IY, et al. Among authors: kim bc, kim sj. Cancer Res. 2002 Jul 1;62(13):3649-53. Cancer Res. 2002. PMID: 12097269

4

The human papilloma virus E7 oncoprotein inhibits transforming growth factor-beta signaling by blocking binding of the Smad complex to its target sequence.

Lee DK, Kim BC, Kim IY, Cho EA, Satterwhite DJ, Kim SJ. Lee DK, et al. Among authors: kim iy, kim bc, kim sj. J Biol Chem. 2002 Oct 11;277(41):38557-64. doi: 10.1074/jbc.M206786200. Epub 2002 Jul 26. J Biol Chem. 2002. PMID: 12145312 Free article.

5

Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines.

Kim IY, Kim BC, Seong DH, Lee DK, Seo JM, Hong YJ, Kim HT, Morton RA, Kim SJ. Kim IY, et al. Among authors: kim bc, kim sj, kim ht. Cancer Res. 2002 Sep 15;62(18):5365-9. Cancer Res. 2002. PMID: 12235008

6

Decreased expression of bone morphogenetic protein (BMP) receptor type II correlates with insensitivity to BMP-6 in human renal cell carcinoma cells.

Kim IY, Lee DH, Lee DK, Kim BC, Kim HT, Leach FS, Linehan WM, Morton RA, Kim SJ. Kim IY, et al. Among authors: kim bc, kim sj, kim ht. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):6046-51. Clin Cancer Res. 2003. PMID: 14676131

7

Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells.

Kim IY, Lee DH, Lee DK, Ahn HJ, Kim MM, Kim SJ, Morton RA. Kim IY, et al. Among authors: kim mm, kim sj. Oncogene. 2004 Oct 7;23(46):7651-9. doi: 10.1038/sj.onc.1207924. Oncogene. 2004. PMID: 15354178

8

Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1.

Kim IY, Lee DH, Lee DK, Kim WJ, Kim MM, Morton RA, Lerner SP, Kim SJ. Kim IY, et al. Among authors: kim mm, kim wj, kim sj. Cancer Res. 2004 Oct 15;64(20):7355-60. doi: 10.1158/0008-5472.CAN-04-0154. Cancer Res. 2004. PMID: 15492256

9

Transforming growth factor-beta : biology and clinical relevance.

Kim IY, Kim MM, Kim SJ. Kim IY, et al. Among authors: kim mm, kim sj. J Biochem Mol Biol. 2005 Jan 31;38(1):1-8. doi: 10.5483/bmbrep.2005.38.1.001. J Biochem Mol Biol. 2005. PMID: 15715939 Review.

10

Role of bone morphogenetic proteins in transitional cell carcinoma cells.

Kim IY, Kim SJ. Kim IY, et al. Among authors: kim sj. Cancer Lett. 2006 Sep 8;241(1):118-23. doi: 10.1016/j.canlet.2005.10.009. Epub 2006 Feb 24. Cancer Lett. 2006. PMID: 16500023 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,296 results

Search Page

Filters